Overview
- The Hong Kong–listed diagnostics firm acquired $19 million of Ether in a HK$149 million block trade executed through HashKey’s OTC desk.
- A strategic partnership with HashKey Exchange secures institutional-grade execution, global liquidity access and asset optimization services.
- IVD is developing ivd.xyz to tokenize pharmaceutical IP and other healthcare assets using Ethereum smart contracts.
- The company plans to launch an ETH-backed IVDD stablecoin for compliant cross-border settlements under Hong Kong and U.S. frameworks.
- IVD will deploy Ether into staking, restaking and on-chain derivatives to enhance yield and manage downside risk.